Abstract

Background: Early identification of sepsis is essential as the mother has a risk of chorioamnionitis. C-reactive protein levels are done along with placental histopathology to detect chorioamnionitis. It is one of the most significant causes of high perinatal morbidity and mortality.

Aim and Objective: To determine c-reactive protein levels and placental histopathology in premature rupture of membranes for maternal chorioamnionitis.

Methodology: A prospective study was conducted in a tertiary care university medical college hospital and research center in western Maharashtra. A total of 250 pregnant women were reported per vaginal leak during the study period and CRP levels were sent along with urine culture sensitivity and high vaginal swab, post-delivery the placenta was sent for histopathology and were included in the study analysis.

Results: The histopathology was done in all 250 pregnant women, and chorioamnionitis was evident in 46 pregnant women. This gives the incidence of 18.4% of chorioamnionitis in the study population. The sensitivity for CRP was calculated to be 15.22%, with a specificity of 99.02%, positive and negative predictive values of 77.78% and 83.82%, respectively, with an accuracy of 83.60%.

Conclusion: Normal CRP level has good predictive values to rule out maternal chorioamnionitis. A raised single CRP level has low sensitivity to predict histological chorioamnionitis prior to its clinical expression.

• 1.   El Taher FT, Afifi NM, Khadija AH, Al Saad AH. C-Reactive Protein in the Premature Rupture of the Membranes. Qatar Med J. 2004 Jun 1;2004(1):10.
• 2.   Assefa NE, Berhe H, Girma F, Berhe K, Berhe YZ, Gebreheat G, et al. Risk factors of premature rupture of membranes in public hospitals at Mekele city, Tigray, a case control study. BMC Pregnancy Childbirth. 2018 Dec;18(1):1-7.
• 3.   Lannon SM, Vanderhoeven JP, Eschenbach DA, Gravett MG, Waldorf KM. Synergy and interactions among biological pathways leading to preterm premature rupture of membranes. Reprod Sci. 2014;21:1215–27.
• 4.   Dayal S, Hong PL. Premature Rupture of Membranes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
• 5.   Czikk MJ, McCarthy FP, Murphy KE. Chorioamnionitis: from pathogenesis to treatment. Clin Microbiol Infect. 2011 Sep;17(9):1304-11.
• 6.   Azizia MM, Irvine LM, Coker M, Sanusi FA. The role of C-reactive protein in modern obstetric and gynecological practice. Acta Obstet Gynecol Scand. 2006;85(4):394-401.
• 7.   Sinha V, Rao JH. Significance of maternal C-reactive protein in preterm prelabor rupture of membrane and its association with histopathological chorioamnionitis. Med Pulse Int J Gynaecol. 2021 Oct;20(1):30-6.
• 8.   Asrat T. Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection, and management. Clin Perinatol. 2001;28:735–51.
• 9.   Stepan M, Cobo T, Musilova I, Hornychova H, Jacobsson B, Kacerovsky M. Maternal serum C-Reactive Protein in women with preterm prelabor rupture of membranes. PLoS One. 2016 Mar 4;11(3):e0150217.

Data Sharing Statement

Funding